دورية أكاديمية

Yao syndrome: a novel systemic autoinflammatory disease with cutaneous manifestations.

التفاصيل البيبلوغرافية
العنوان: Yao syndrome: a novel systemic autoinflammatory disease with cutaneous manifestations.
المؤلفون: Shakhashiro M; University of Kentucky College of Medicine, Lexington, KY, USA., Sadeghian S; Michael G. DeGroote School of Medicine, McMaster University, Hamilton, ON, Canada., Newcomer J; Department of Dermatology, Mayo Clinic, Rochester, MN, USA., Marzano AV; Dermatology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.; Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Milan, Italy., Maronese CA; Dermatology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.; Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Milan, Italy., Davis JM 3rd; Division of Rheumatology, Mayo Clinic, Rochester, MN, USA., Alavi A; Department of Dermatology, Mayo Clinic, Rochester, MN, USA.
المصدر: International journal of dermatology [Int J Dermatol] 2024 Jul 04. Date of Electronic Publication: 2024 Jul 04.
Publication Model: Ahead of Print
نوع المنشور: Journal Article; Review
اللغة: English
بيانات الدورية: Publisher: Blackwell Science Country of Publication: England NLM ID: 0243704 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-4632 (Electronic) Linking ISSN: 00119059 NLM ISO Abbreviation: Int J Dermatol Subsets: MEDLINE
أسماء مطبوعة: Publication: Oxford : Blackwell Science
Original Publication: Philadelphia, Lippincott.
مستخلص: Yao syndrome (YAOS) is a novel systemic autoinflammatory disease linked to the nucleotide-binding oligomerization domain (NOD2) gene. It is characterized by periodic fevers, gastrointestinal (GI) symptoms, arthritis, and dermatitis, among other symptoms. A sparse literature exists on this disease, and little is known about its dermatological manifestations. A review of available literature was performed to characterize the cutaneous manifestations of Yao syndrome. Cutaneous manifestations were documented in 85.7% of patients, with common characteristic descriptions of erythematous patches and plaques involving the face, trunk, abdomen, and extremities. Based on our review of treatment modalities employed for Yao syndrome, prednisone is an appropriate initial approach, with oral sulfasalazine and other disease-modifying antirheumatic drugs serving as appropriate secondary options. YAOS should be considered in the differential diagnosis of patients presenting with a dermatitic rash, especially in the context of concurrent articular symptoms, periodic fever, and GI symptoms.
(© 2024 the International Society of Dermatology.)
References: Yao Q, Zhou L, Cusumano P, Bose N, Piliang M, Jayakar B, et al. A new category of autoinflammatory disease associated with NOD2 gene mutations. Arthritis Res Ther. 2011;13(5):R148.
Yao Q, Shen M, McDonald C, Lacbawan F, Moran R, Shen B. NOD2‐associated autoinflammatory disease: a large cohort study. Rheumatology. 2015;54(10):1904–1912.
Rivera EG, Patnaik A, Salvemini J, Jain S, Lee K, Lozeau D, et al. SARS‐CoV‐2/COVID 19 and its relationship with NOD2 and ubiquitination. Clin Immunol. 2022;238:109027.
Trueb B, Zhuang L, Keller I, Kockritz LV, Kuchen S, Dufour JF, et al. Coincidence of NOD2‐associated autoinflammatory disease (Yao Syndrome) and HCV infection with fatal consequences: interaction between genes and environment. J Clin Rheumatol. 2021;27(8S):S592–S594.
Brailsford CJ, Khamdan F, Elston DM. Treatment of refractory Yao syndrome with canakinumab. JAAD Case Rep. 2022;29:37–40.
McDonald C, Shen M, Johnson EE, Kabi A, Yao Q. Alterations in nucleotide‐binding oligomerization domain‐2 expression, pathway activation, and cytokine production in Yao syndrome. Autoimmunity. 2018;51(2):53–61.
Yao Q, Shen B. A systematic analysis of treatment and outcomes of NOD2‐associated autoinflammatory disease. Am J Med. 2017;130(3):365 e13‐e18.
Wu D, Shen M, Yao Q. Cutaneous manifestations of autoinflammatory diseases. Rheumatol Immunol Res. 2021;2(4):217–225.
Farhi D, Cosnes J, Zizi N, Chosidow O, Seksik P, Beaugerie L, et al. Significance of erythema nodosum and pyoderma gangrenosum in inflammatory bowel diseases: a cohort study of 2402 patients. Medicine. 2008;87(5):281–293.
Yao Q, Su LC, Tomecki KJ, Zhou L, Jayakar B, Shen B. Dermatitis as a characteristic phenotype of a new autoinflammatory disease associated with NOD2 mutations. J Am Acad Dermatol. 2013;68(4):624–631.
Yao Q, Schils J. Distal lower extremity swelling as a prominent phenotype of NOD2‐associated autoinflammatory disease. Rheumatology (Oxford). 2013;52(11):2095–2097.
Yao Q, Kontzias A. Expansion of phenotypic and genotypic spectrum in yao syndrome: a case series. J Clin Rheumatol. 2022;28(1):e156–e160.
Yang X, Wu D, Li J, Shen M, Zhang W. A Chinese case series of Yao syndrome and literature review. Clin Rheumatol. 2018;37(12):3449–3454.
Hua Y, Wu D, Shen M, Yu K, Zhang W, Zeng X. Phenotypes and genotypes of Chinese adult patients with systemic autoinflammatory diseases. Semin Arthritis Rheum. 2019;49(3):446–452.
Shen M, Moran R, Tomecki KJ, Yao Q. Granulomatous disease associated with NOD2 sequence variants and familial camptodactyly: An intermediate form of NOD2‐associated diseases? Semin Arthritis Rheum. 2015;45(3):357–360.
Dziedzic M, Marjańska A, Bąbol‐Pokora K, Urbańczyk A, Grześk E, Młynarski W, et al. Co‐existence of Blau syndrome and NAID? Diagnostic challenges associated with presence of multiple pathogenic variants in NOD2 gene: a case report. Pediatr Rheumatol Online J. 2017;15(1):57.
Yao Q, Myles J, Shen B, McDonald C. NOD2‐associated autoinflammatory disease: an exploratory study of its pathogenesis. Rheumatology (Oxford). 2014;53(5):958–960.
Borzutzky A, Fried A, Chou J, Bonilla FA, Kim S, Dedeoglu F. NOD2‐associated diseases: bridging innate immunity and autoinflammation. Clin Immunol. 2010;134(3):251–261.
Estephan M, Yao Q, Springer J. Case of NOD2‐associated autoinflammatory disease successfully treated with sulfasalazine. J Clin Rheumatol. 2017;23(1):58–59.
فهرسة مساهمة: Keywords: NOD2; Yao syndrome; autoinflammatory disease; cutaneous manifestations; narrative review
تواريخ الأحداث: Date Created: 20240704 Latest Revision: 20240704
رمز التحديث: 20240705
DOI: 10.1111/ijd.17350
PMID: 38965064
قاعدة البيانات: MEDLINE
الوصف
تدمد:1365-4632
DOI:10.1111/ijd.17350